- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01555619
Quadripolar Pacing Post Approval Study (Quad PAS)
April 12, 2019 updated by: Abbott Medical Devices
The purpose of this post-approval study is to evaluate the acute and chronic performance of a Quadripolar CRT-D device system in a patient population indicated for cardiac resynchronization therapy (CRT).
Study Overview
Detailed Description
Quad PAS is a multi-center, post-approval study.
Patients who meet inclusion/exclusion criteria will have an attempted implant of a Quadripolar CRT-D device system (device and left ventricular (LV) lead).
Patients who have an unsuccessful implant will be followed for 30 days for any adverse events and then withdrawn from the study, or may have an implant reattempted if the physician chooses to do so.
Patients enrolled in the study will be followed at 6 months, and every 6 months thereafter, for 60 months of follow up (5 years).
After patients complete 60 months of follow-up, their participation in the study will be terminated.
Study Type
Observational
Enrollment (Actual)
1971
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35211
- Cardiology, P.C.
-
Huntsville, Alabama, United States, 35801
- Heart Center Research, LLC/Research Center
-
Montgomery, Alabama, United States, 36116
- Southeastern Cardiology Consultants PC
-
-
Arizona
-
Phoenix, Arizona, United States, 85006
- Arizona Arrhythmia Research Center
-
-
Arkansas
-
Fayetteville, Arkansas, United States, 72703
- Washington Regional Medical Center
-
Little Rock, Arkansas, United States, 72211
- Arkansas Heart Hospital
-
-
California
-
Bakersfield, California, United States, 93309
- Comprehensive Cardiovascular
-
La Jolla, California, United States, 92037
- Scripps Green Hospital
-
Los Angeles, California, United States, 90033
- USC Unversity Hospital
-
Mountain View, California, United States, 94040
- Fogarty Institute
-
Newport Beach, California, United States, 92663
- Premier Cardiology, Inc.
-
Northridge, California, United States, 91325
- Cardiac Rhythm Specialists, Inc.
-
Orange, California, United States, 92868
- St. Joseph Heritage Medical Group
-
Sacramento, California, United States, 95819
- Regional Cardiology Associates
-
Stockton, California, United States, 95204
- St. Joseph's Medical Center
-
Ventura, California, United States, 93003
- Cardiology Associates Medical Group, Inc.
-
-
Florida
-
Atlantis, Florida, United States, 33462
- Florida Electrophysiology Associates
-
Boynton Beach, Florida, United States, 33437
- Yoel R. Vivas, MD
-
Lake Mary, Florida, United States, 32746
- Jorge Diaz
-
Naples, Florida, United States, 34102
- Naples Heart Rhythm Specialists
-
Ocala, Florida, United States, 34471
- Munroe Regional Medical Center
-
Plantation, Florida, United States, 33324
- Florida Heart Rhythm Specialists, LLC
-
Saint Petersburg, Florida, United States, 33709
- Northside Hospital
-
Weston, Florida, United States, 33331
- Cleveland Clinic Florida
-
-
Georgia
-
Atlanta, Georgia, United States, 30309
- Piedmont Heart Institue
-
-
Illinois
-
Peoria, Illinois, United States, 61614
- HeartCare Midwest
-
-
Indiana
-
Fort Wayne, Indiana, United States, 46805
- Parkview Research Center
-
Munster, Indiana, United States, 46321
- Northwest Indiana CardiovascularPhysicians, P.C.
-
-
Iowa
-
Cedar Rapids, Iowa, United States, 52403
- Unity Point Clinic
-
-
Kentucky
-
Lexington, Kentucky, United States, 40503
- Central Baptist Hospital
-
-
Maine
-
Bangor, Maine, United States, 04401
- Northeast Cardiology Associates
-
-
Maryland
-
Baltimore, Maryland, United States, 21237
- MedStar Health Research Institute
-
Rockville, Maryland, United States, 20850
- Shady Grove Adventist Hospital
-
-
Massachusetts
-
Burlington, Massachusetts, United States, 01805
- Lahey Clinic
-
-
Michigan
-
Detroit, Michigan, United States, 48235
- Sinai Grace Hospital
-
Lansing, Michigan, United States, 48910
- Thoracic Cardio Healthcare Foundation
-
-
Missouri
-
Saint Louis, Missouri, United States, 63131
- Missouri Baptist Medical Center
-
-
Montana
-
Missoula, Montana, United States, 59802
- The International Heart Institute of Montana
-
-
Nebraska
-
Omaha, Nebraska, United States, 68122
- Heart Consultants P.C.
-
-
Nevada
-
Las Vegas, Nevada, United States, 89109
- Cardiovascular Consultants of Nevada
-
-
New Jersey
-
Browns Mills, New Jersey, United States, 08015
- Deborah Heart and Lung Center
-
Haddon Heights, New Jersey, United States, 08035
- Cardiovascular Associates of the Delaware Valley
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87106
- Presbyterian Heart Group
-
-
New York
-
Albany, New York, United States, 12208
- Albany Medical College at Albany Medical Center
-
Stony Brook, New York, United States, 11794
- Stonybrook University Medical Center
-
Williamsville, New York, United States, 14221
- Buffalo Cardiology & Pulmonary Association
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina at Chapel Hill
-
Gastonia, North Carolina, United States, 28054
- Caromount Heart
-
-
North Dakota
-
Fargo, North Dakota, United States, 58122
- Sanford Research
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- The Cleveland Clinic Foundation
-
Elyria, Ohio, United States, 44035
- EMH Regional Medical Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73112
- INTEGRIS Baptist Medical Center
-
-
Pennsylvania
-
Bryn Mawr, Pennsylvania, United States, 19010
- Bryn Mawr Medical Specialists Associates
-
Erie, Pennsylvania, United States, 16502
- Saint Vincent Consultants in Cardiovascular Diseases
-
Lancaster, Pennsylvania, United States, 17603
- Lancaster General Hospital
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
South Carolina
-
Florence, South Carolina, United States, 29506
- Pee Dee Cardiology Associates, PA
-
-
Tennessee
-
Johnson City, Tennessee, United States, 37601
- Cardiology Consultants
-
Kingsport, Tennessee, United States, 37660
- Cardiovascular Associates, Pc
-
Memphis, Tennessee, United States, 38104
- Arrythmia Consultants, P.C.
-
Nashville, Tennessee, United States, 37205
- St. Thomas Hospital
-
-
Texas
-
Bedford, Texas, United States, 76021
- HeartPlace
-
Corpus Christi, Texas, United States, 78404
- Cardiology Associatesof Corpus Christi
-
Houston, Texas, United States, 77024
- Houston Arrhythmia Associates
-
-
Utah
-
Salt Lake City, Utah, United States, 84132
- Medicine School of University Health Care
-
-
Vermont
-
Burlington, Vermont, United States, 05401
- Fletcher Allen Health Care - University Health Center Campus
-
-
Virginia
-
Harrisonburg, Virginia, United States, 22801
- Harrisonburg Medical Associations, Inc.
-
Richmond, Virginia, United States, 23229
- Virginia Cardiovascular Specialists
-
-
Washington
-
Spokane, Washington, United States, 99204
- Heart Clinics Northwest
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26505
- Morgantown Internal Medicine Group, Inc.
-
-
Wisconsin
-
Wausau, Wisconsin, United States, 54401
- Aspirius Heart and Vascular Institute, Research and Education
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients indicated for CRT.
Description
Inclusion Criteria:
- Approved indication per current American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for implantation of a CRT-D system for treatment of heart failure or life threatening ventricular tachyarrhythmia(s).
- Participated in the Promote® Q CRT-D and Quartet™ Left Ventricular Heart Lead Study (Investigational Device Exemption (IDE) study), or are receiving a new Quadripolar CRT-D device system implant or are undergoing an upgrade from an existing implantable cardioverter-defibrillator or pacemaker implant with no prior LV lead placement.
- Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluations
Exclusion Criteria:
- Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate
- Have a life expectancy of less than 5 years due to any condition
- Be less than 18 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CRT-D System
St. Jude Medical (SJM) Promote® Q/Promote® Quadra/Unify Quadra™ CRT-D system.
|
Implantation of a CRT-D System
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complication free survival rate related to the CRT-D system
Time Frame: 5 years
|
Complication free survival rate through 5 years for complications related to the CRT-D system
|
5 years
|
|
Complication free survival rate related to the LV lead
Time Frame: 5 years
|
Complication free survival rate at 5 years for complications related to the LV lead
|
5 years
|
|
Mean programmed LV lead pacing capture threshold
Time Frame: 5 years
|
Mean programmed LV lead pacing capture threshold at 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Raffaele Corbisiero, MD, Deborah Heart and Lung Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 15, 2012
Primary Completion (ACTUAL)
February 28, 2019
Study Completion (ACTUAL)
February 28, 2019
Study Registration Dates
First Submitted
March 13, 2012
First Submitted That Met QC Criteria
March 14, 2012
First Posted (ESTIMATE)
March 15, 2012
Study Record Updates
Last Update Posted (ACTUAL)
April 16, 2019
Last Update Submitted That Met QC Criteria
April 12, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60030283
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
Clinical Trials on CRT-D System
-
University Medical Center GroningenMaastricht University Medical Center; UMC Utrecht; Academisch Medisch Centrum... and other collaboratorsCompleted
-
University Hospital OlomoucNot yet recruiting
-
Medtronic Cardiac Rhythm and Heart FailureMedtronicTerminatedHeart Failure, CongestiveGermany
-
Semmelweis University Heart and Vascular CenterSheba Medical Center; University of Rochester; Pharmahungary GroupCompletedCardiomyopathyHungary, Germany, Serbia, Slovenia, Israel, Poland, Slovakia
-
Boston Scientific CorporationCompleted
-
Helios Health Institute GmbHHeart Center Leipzig - University HospitalTerminatedChronic Heart FailureGermany
-
Boston Scientific CorporationGuidant CorporationTerminated
-
Boston Scientific CorporationCompletedLeft Ventricular DysfunctionUnited States
-
University of Rome Tor VergataUnknownHeart Failure | Ventricular Fibrillation | Ventricular TachycardiaItaly
-
Boston Scientific CorporationCompletedHeart Failure | Atrial Fibrillation | Ventricular Fibrillation | Tachycardia | Atrial FlutterGermany